Aaron G.l. Fletcher, Director at Cue Biopharma, Inc. (CUE), bought 15,000 shares at $25.24 ($373K) on 2020-06-24, disclosed to the SEC on 2020-06-25.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $24.64 | 4,547 | $112K | 30.0% |
| 2 | $24.64 | 4,547 | $112K | 30.0% |
| 3 | $25.24 | 2,953 | $75K | 20.0% |
| 4 | $25.24 | 2,953 | $75K | 20.0% |
| Total | $24.88 avg | 15,000 | $373K | 100% |
| Filing → |
| TFFP | BUY | 2022-11-23 | $50K | — | Filing → |
| CUE | BUY | 2022-05-25 | $712K | — | Filing → |
| TFFP | BUY | 2022-05-17 | $538K | — | Filing → |